Skip to main content
Top
Published in: European Journal of Nuclear Medicine and Molecular Imaging 6/2007

01-06-2007 | Molecular Imaging

Molecular imaging of vascular cell adhesion molecule-1 expression in experimental atherosclerotic plaques with radiolabelled B2702-p

Authors: A. Broisat, L. M. Riou, V. Ardisson, D. Boturyn, P. Dumy, D. Fagret, C. Ghezzi

Published in: European Journal of Nuclear Medicine and Molecular Imaging | Issue 6/2007

Login to get access

Abstract

Purpose

VCAM-1 plays a major role in the chronic inflammatory processes present in vulnerable atherosclerotic plaques. The residues 75–84 (B2702-p) and 84–75/75–84 (B2702-rp) of the major histocompatibility complex-1 (MHC-1) molecule B2702 were previously shown to bind specifically to VCAM-1. We hypothesised that radiolabelled B2702-p and B2702-rp might have potential for the molecular imaging of vascular cell adhesion molecule-1 (VCAM-1) expression in atherosclerotic plaques.

Methods

Preliminary biodistribution studies indicated that 125I-B2702-rp was unsuitable for in vivo imaging owing to extremely high lung uptake. 123I- or 99mTc-labelled B2702-p was injected intravenously to Watanabe heritable hyperlipidaemic rabbits (WHHL, n = 6) and control animals (n = 6). After 180 min, aortas were harvested for ex vivo autoradiographic imaging, gamma-well counting, VCAM-1 immunohistology and Sudan IV lipid staining.

Results

Robust VCAM-1 immunostaining was observed in Sudan IV-positive and to a lesser extent in Sudan IV-negative areas of WHHL animals, whereas no expression was detected in control animals. Significant 2.9-fold and 1.9-fold increases in 123I-B2702-p and 99mTc-B2702-p aortic-to-blood ratios, respectively, were observed between WHHL and control animals (p < 0.05). Tracer uptake on ex vivo images co-localised with atherosclerotic plaques. Image quantification indicated a graded increase in 123I-B2702-p and 99mTc-B2702-p activities from control to Sudan IV-negative and to Sudan IV-positive areas, consistent with the observed pattern of VCAM-1 expression. Sudan IV-positive to control area tracer activity ratios were 17.0 ± 9.0 and 5.9 ± 1.8 for 123I-B2702-p and 99mTc-B2702-p, respectively.

Conclusion

Radiolabelled B2702-p is a potentially useful radiotracer for the molecular imaging of VCAM-1 in atherosclerosis.
Literature
1.
go back to reference Fuster V. Mechanisms leading to myocardial infarction: insights from studies of vascular biology. Circulation 1995;9:2126–46. Fuster V. Mechanisms leading to myocardial infarction: insights from studies of vascular biology. Circulation 1995;9:2126–46.
2.
go back to reference Libby P. Molecular bases of the acute coronary syndromes. Circulation 1995;91:2844–50.PubMed Libby P. Molecular bases of the acute coronary syndromes. Circulation 1995;91:2844–50.PubMed
6.
go back to reference Naghavi M, Libby P, Falk E, Casscells SW, Litovsky S, Rumberger J, et al. From vulnerable plaque to vulnerable patient. A call for new definitions and risk assessment strategies: part I. Circulation 2003;108:1664–72.PubMedCrossRef Naghavi M, Libby P, Falk E, Casscells SW, Litovsky S, Rumberger J, et al. From vulnerable plaque to vulnerable patient. A call for new definitions and risk assessment strategies: part I. Circulation 2003;108:1664–72.PubMedCrossRef
8.
go back to reference Chia MC. The role of adhesion molecules in atherosclerosis. Crit Rev Clin Lab Sci 1998;35:573–602.PubMedCrossRef Chia MC. The role of adhesion molecules in atherosclerosis. Crit Rev Clin Lab Sci 1998;35:573–602.PubMedCrossRef
10.
go back to reference Osborn L, Hession C, Tizard R, Vassallo C, Luhowskyj S, Chi-Rosso G, et al. Direct expression cloning of vascular cell adhesion molecule 1, a cytokine-induced endothelial protein that binds to lymphocytes. Cell 1989;59:1203–11.PubMedCrossRef Osborn L, Hession C, Tizard R, Vassallo C, Luhowskyj S, Chi-Rosso G, et al. Direct expression cloning of vascular cell adhesion molecule 1, a cytokine-induced endothelial protein that binds to lymphocytes. Cell 1989;59:1203–11.PubMedCrossRef
11.
go back to reference Aikawa M, Libby P. The vulnerable atherosclerotic plaque: pathogenesis and therapeutic approach. Cardiovasc Pathol 2004;13:125–38.PubMedCrossRef Aikawa M, Libby P. The vulnerable atherosclerotic plaque: pathogenesis and therapeutic approach. Cardiovasc Pathol 2004;13:125–38.PubMedCrossRef
12.
go back to reference Cybulsky MI, Gimbrone MA. Endothelial expression of a mononuclear leucocyte adhesion molecule during atherogenesis. Science 1991;251:788–91.PubMedCrossRef Cybulsky MI, Gimbrone MA. Endothelial expression of a mononuclear leucocyte adhesion molecule during atherogenesis. Science 1991;251:788–91.PubMedCrossRef
13.
go back to reference Malek AH, Alper SL, Izumo S. Hemodynamic shear stress and its role in atherosclerosis. JAMA 1999;282:2035–42.PubMedCrossRef Malek AH, Alper SL, Izumo S. Hemodynamic shear stress and its role in atherosclerosis. JAMA 1999;282:2035–42.PubMedCrossRef
14.
go back to reference Iiyama K, Hajra L, Iiyama M, Li H, DiChiara M, Medoff BD, et al. Pattern of vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 expression in rabbit and mouse atherosclerotic lesions and at sites predisposed to lesion formation. Circ Res 1999;85:199–207.PubMed Iiyama K, Hajra L, Iiyama M, Li H, DiChiara M, Medoff BD, et al. Pattern of vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 expression in rabbit and mouse atherosclerotic lesions and at sites predisposed to lesion formation. Circ Res 1999;85:199–207.PubMed
16.
go back to reference Cybulsky MI, Liyama K, Li H, Zhu S, Chen M, Iiyama M, et al. A major role for VCAM-1 but not ICAM-1, in early atherosclerosis. J Clin Invest 2001;107:1255–62.PubMed Cybulsky MI, Liyama K, Li H, Zhu S, Chen M, Iiyama M, et al. A major role for VCAM-1 but not ICAM-1, in early atherosclerosis. J Clin Invest 2001;107:1255–62.PubMed
17.
go back to reference Ling X, Tamaki T, Xiao Y, Kamangar S, Clayberger C, Lewis DB, et al. An immunosuppressive and anti-inflammatory HLA class I-derived peptides binds vascular cell adhesion molecule-1. Transplantation 2000;70:662–7.PubMedCrossRef Ling X, Tamaki T, Xiao Y, Kamangar S, Clayberger C, Lewis DB, et al. An immunosuppressive and anti-inflammatory HLA class I-derived peptides binds vascular cell adhesion molecule-1. Transplantation 2000;70:662–7.PubMedCrossRef
18.
go back to reference Nossner E, Golberg JE, Naftzger C, Lyu SC, Clayberger C, Krensky AM. HLA-derived peptides which inhibit T cell function bind to members of the heat-shock protein 70 family. J Exp Med 1996;183:339–48.PubMedCrossRef Nossner E, Golberg JE, Naftzger C, Lyu SC, Clayberger C, Krensky AM. HLA-derived peptides which inhibit T cell function bind to members of the heat-shock protein 70 family. J Exp Med 1996;183:339–48.PubMedCrossRef
19.
go back to reference Sörme P, Kahl-Knutsson B, Huflejt M, Nilsson UJ, Leffler H. Fluorescence polarization as an analytical tool to evaluate galectin-ligand interactions. Anal Biochem 2004;334:36–47.PubMedCrossRef Sörme P, Kahl-Knutsson B, Huflejt M, Nilsson UJ, Leffler H. Fluorescence polarization as an analytical tool to evaluate galectin-ligand interactions. Anal Biochem 2004;334:36–47.PubMedCrossRef
20.
go back to reference Tsimikas S, Palinski W, Halpern SE, Yeung DW, Curtiss LK, Witztum JL. Radiolabeled MDA2, an oxidation-specific, monoclonal antibody, identifies native atherosclerotic lesions in vivo. J Nucl Cardiol 1999;6:41–53.PubMedCrossRef Tsimikas S, Palinski W, Halpern SE, Yeung DW, Curtiss LK, Witztum JL. Radiolabeled MDA2, an oxidation-specific, monoclonal antibody, identifies native atherosclerotic lesions in vivo. J Nucl Cardiol 1999;6:41–53.PubMedCrossRef
21.
go back to reference O’Brien KD, Allen MD, McDonald TO, Chait A, Harlan JM, Fishbein D, et al. Vascular cell adhesion molecule-1 is expressed in human coronary atherosclerotic plaques. J Clin Invest 1993;92:945–51.PubMed O’Brien KD, Allen MD, McDonald TO, Chait A, Harlan JM, Fishbein D, et al. Vascular cell adhesion molecule-1 is expressed in human coronary atherosclerotic plaques. J Clin Invest 1993;92:945–51.PubMed
22.
go back to reference O’Brien KD, McDonald TO, Chait A, Allen MD, Alpers CE. Neovascular expression of E-selectin, intercellular adhesion molecule-1 and vascular adhesion molecule-1 in human atherosclerosis and their relation to intimal leucocyte content. Circulation 1996;93:672–82.PubMed O’Brien KD, McDonald TO, Chait A, Allen MD, Alpers CE. Neovascular expression of E-selectin, intercellular adhesion molecule-1 and vascular adhesion molecule-1 in human atherosclerosis and their relation to intimal leucocyte content. Circulation 1996;93:672–82.PubMed
23.
go back to reference Kondo T, Watanabe Y. A heritable hyperlipidemic rabbit. Jikken Dobutsu 1975;24:89–94.PubMed Kondo T, Watanabe Y. A heritable hyperlipidemic rabbit. Jikken Dobutsu 1975;24:89–94.PubMed
24.
go back to reference Buja LM, Clubb FJ, Bilheimer, Willerson JT. Pathobiology of human familial hypercholesterolemia and a related animal model, the Watanabe heritable hyperlipidaemic rabbit. Eur Heart J 1990;11(Suppl E):41–52.PubMed Buja LM, Clubb FJ, Bilheimer, Willerson JT. Pathobiology of human familial hypercholesterolemia and a related animal model, the Watanabe heritable hyperlipidaemic rabbit. Eur Heart J 1990;11(Suppl E):41–52.PubMed
25.
go back to reference Clubb FJ, Cerny JL, Defarrari DA, Butler-Aucoin MM, Willerson JT, Buja M. Development of atherosclerotic plaque with endothelial disruption in Watanabe heritable hyperlipidemic rabbit aorta. Cardiovasc Pathol 2001;9:1–11.CrossRef Clubb FJ, Cerny JL, Defarrari DA, Butler-Aucoin MM, Willerson JT, Buja M. Development of atherosclerotic plaque with endothelial disruption in Watanabe heritable hyperlipidemic rabbit aorta. Cardiovasc Pathol 2001;9:1–11.CrossRef
26.
go back to reference Fruebis J, Gonzalez V, Silvestre M, Palinski W. Effect of probucol treatment on gene expression of VCAM-1, MCP-1, and M-CSF in the aortic wall of LDL receptor-deficient rabbits during early atherogenesis. Arterioscler Thromb Vasc Biol 1997;17:1289–302.PubMed Fruebis J, Gonzalez V, Silvestre M, Palinski W. Effect of probucol treatment on gene expression of VCAM-1, MCP-1, and M-CSF in the aortic wall of LDL receptor-deficient rabbits during early atherogenesis. Arterioscler Thromb Vasc Biol 1997;17:1289–302.PubMed
27.
go back to reference Hartung D, Sarai M, Petrov A, Kolodgie F, Narula N, Verjans J, et al. Resolution of apoptosis in atherosclerotic plaque by dietary modification and statin therapy. J Nucl Med 2005;46:2051–6.PubMed Hartung D, Sarai M, Petrov A, Kolodgie F, Narula N, Verjans J, et al. Resolution of apoptosis in atherosclerotic plaque by dietary modification and statin therapy. J Nucl Med 2005;46:2051–6.PubMed
28.
go back to reference Strauss HW, Grewal RK, Pandit-Taskar N. Molecular imaging in nuclear cardiology. Semin Nucl Med 2004;34:47–55.PubMedCrossRef Strauss HW, Grewal RK, Pandit-Taskar N. Molecular imaging in nuclear cardiology. Semin Nucl Med 2004;34:47–55.PubMedCrossRef
29.
go back to reference Kolodgie FD, Petrov A, Virmani R, Narula N, Verjans JW, Weber DK, et al. Targeting of apoptotic macrophages and experimental atheroma with radiolabelled annexin V. Circulation 2003;108:3134–9.PubMedCrossRef Kolodgie FD, Petrov A, Virmani R, Narula N, Verjans JW, Weber DK, et al. Targeting of apoptotic macrophages and experimental atheroma with radiolabelled annexin V. Circulation 2003;108:3134–9.PubMedCrossRef
30.
go back to reference Ohtsuki K, Hayase M, Akashi K, Kopiwoda S, Strauss HW. Detection of monocyte chemoattractant protein-1 in experimental atherosclerotic lesions. Circulation 2001;104:203–8.PubMed Ohtsuki K, Hayase M, Akashi K, Kopiwoda S, Strauss HW. Detection of monocyte chemoattractant protein-1 in experimental atherosclerotic lesions. Circulation 2001;104:203–8.PubMed
31.
go back to reference Strauss HW, Blankenberg FG. Small is beautiful: specialty imaging devices and the growth of nuclear cardiology. J Nucl Med 2000;7:175–9. Strauss HW, Blankenberg FG. Small is beautiful: specialty imaging devices and the growth of nuclear cardiology. J Nucl Med 2000;7:175–9.
32.
go back to reference Moreno PR, Muller JE. Identification of high-risk atherosclerotic plaques: a survey of spectroscopic methods. Curr Op Cardiol 2002;17:638–47.CrossRef Moreno PR, Muller JE. Identification of high-risk atherosclerotic plaques: a survey of spectroscopic methods. Curr Op Cardiol 2002;17:638–47.CrossRef
33.
go back to reference MacNeill BD, Lowe HC, Takano M, Fuster V, Jang IK. Intravascular modalities for detection of vulnerable plaque: current status. Artherioscler Thromb Vasc Biol 2003;23:1333–42.CrossRef MacNeill BD, Lowe HC, Takano M, Fuster V, Jang IK. Intravascular modalities for detection of vulnerable plaque: current status. Artherioscler Thromb Vasc Biol 2003;23:1333–42.CrossRef
34.
go back to reference Ogawa M, Ishino S, Mukai T, Asano D, Teramoto N, Watabe H, et al. 18F-FDG accumulation in atherosclerotic plaques: immunohistochemical and PET imaging study. J Nucl Med 2004;45:1245–50.PubMed Ogawa M, Ishino S, Mukai T, Asano D, Teramoto N, Watabe H, et al. 18F-FDG accumulation in atherosclerotic plaques: immunohistochemical and PET imaging study. J Nucl Med 2004;45:1245–50.PubMed
35.
go back to reference Vallabhajosula S, Fuster V. Atherosclerosis: imaging techniques and the evolving role of nuclear medicine. J Nucl Med 1997;38:1788–96.PubMed Vallabhajosula S, Fuster V. Atherosclerosis: imaging techniques and the evolving role of nuclear medicine. J Nucl Med 1997;38:1788–96.PubMed
36.
go back to reference Mitchel J, Waters D, Lai T, White M, Alberghini T, Salloum A, et al. Identification of coronary thrombus with a IIb/IIIa platelet inhibitor radiopharmaceutical, technetium-99m DMP-444: a canine model. Circulation 2000;101:1643–6.PubMed Mitchel J, Waters D, Lai T, White M, Alberghini T, Salloum A, et al. Identification of coronary thrombus with a IIb/IIIa platelet inhibitor radiopharmaceutical, technetium-99m DMP-444: a canine model. Circulation 2000;101:1643–6.PubMed
37.
go back to reference Tsimikas S. Noninvasive imaging of oxidized low-density lipoprotein in atherosclerotic plaques with tagged oxidation-specific antibodies. Am J Cardiol 2002;90(suppl L):22–7.CrossRef Tsimikas S. Noninvasive imaging of oxidized low-density lipoprotein in atherosclerotic plaques with tagged oxidation-specific antibodies. Am J Cardiol 2002;90(suppl L):22–7.CrossRef
38.
go back to reference Petrov A, Hartung D, Kolodgie F, Narula N, Haider N, Kohut A, et al. Imaging inflammation in atherosclerotic lesions by radiolabeled chemotactic peptide: would identification of vulnerable plaques become feasible? ACC 2003 835-1. J Am Coll Cardiol 2003;19:445-A. Petrov A, Hartung D, Kolodgie F, Narula N, Haider N, Kohut A, et al. Imaging inflammation in atherosclerotic lesions by radiolabeled chemotactic peptide: would identification of vulnerable plaques become feasible? ACC 2003 835-1. J Am Coll Cardiol 2003;19:445-A.
39.
go back to reference Johnson LL, Schofield L, Donahay T, Narula N, Narula J. 99mTc-Annexin V imaging for detection of atherosclerotic lesions in porcine coronary arteries. J Nucl Med 2005;46:1186–93.PubMed Johnson LL, Schofield L, Donahay T, Narula N, Narula J. 99mTc-Annexin V imaging for detection of atherosclerotic lesions in porcine coronary arteries. J Nucl Med 2005;46:1186–93.PubMed
40.
go back to reference Schafers M, Rieman B, Kopka K, Breyholz HJ, Wagner S, Schäfers KP, et al. Scintigraphic imaging of matrix metalloproteinase activity in the arterial wall in vivo. Circulation 2004;109:2554–9.PubMedCrossRef Schafers M, Rieman B, Kopka K, Breyholz HJ, Wagner S, Schäfers KP, et al. Scintigraphic imaging of matrix metalloproteinase activity in the arterial wall in vivo. Circulation 2004;109:2554–9.PubMedCrossRef
41.
go back to reference Galili O, Herrmann J, Woodrum J, Sattler KJ, Lerman LO, Lerman A. Adventitial vasa vasorum heterogeneity among different vascular beds. J Vasc Surg. 2004;40:529–35.PubMedCrossRef Galili O, Herrmann J, Woodrum J, Sattler KJ, Lerman LO, Lerman A. Adventitial vasa vasorum heterogeneity among different vascular beds. J Vasc Surg. 2004;40:529–35.PubMedCrossRef
42.
go back to reference Strauss HW, Narula J, Blankenberg FG. Radioimaging to identify myocardial cell death and probably injury. Lancet 2000;356:180–1.PubMedCrossRef Strauss HW, Narula J, Blankenberg FG. Radioimaging to identify myocardial cell death and probably injury. Lancet 2000;356:180–1.PubMedCrossRef
43.
go back to reference Kietselaer BL, Reutelingsperger CP, Heidendal GA, Daemen MJ, Mess WH, Hofstra L, et al. Noninvasive detection of plaque instability with use of radiolabeled annexin-5 in patients with carotid-artery atherosclerosis. N Engl J Med 2004;350:1472–3.PubMedCrossRef Kietselaer BL, Reutelingsperger CP, Heidendal GA, Daemen MJ, Mess WH, Hofstra L, et al. Noninvasive detection of plaque instability with use of radiolabeled annexin-5 in patients with carotid-artery atherosclerosis. N Engl J Med 2004;350:1472–3.PubMedCrossRef
Metadata
Title
Molecular imaging of vascular cell adhesion molecule-1 expression in experimental atherosclerotic plaques with radiolabelled B2702-p
Authors
A. Broisat
L. M. Riou
V. Ardisson
D. Boturyn
P. Dumy
D. Fagret
C. Ghezzi
Publication date
01-06-2007
Publisher
Springer-Verlag
Published in
European Journal of Nuclear Medicine and Molecular Imaging / Issue 6/2007
Print ISSN: 1619-7070
Electronic ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-006-0310-4

Other articles of this Issue 6/2007

European Journal of Nuclear Medicine and Molecular Imaging 6/2007 Go to the issue

Society communications

Society communications